Abstract:Background: It was well studied that HER2/ErbB2/p185 overexpression in human malignant cancers correlates with poor prognosis and chemo-resistance. Meanwhile, Genistein (4,5,7trihydroxyisoflavone), a major isoflavone component of soybeans and other leguminous plants, has been shown to exhibit a potent anti-proliferative effect on some sex hormone dependent cancers. Objective: The effects of genistein on the proliferation of human HER2-overexpressing breast and ovarian cancer cell lines were investigated, and the action mechanism was explored. Methods: Western blotting, fluorescence-activated cell sorting (FACS) and immunofluorescence methods, cell proliferation assay kit from Promega and cell apoptosis assay kit from Biolegend were used. The doseor time-response relationship of genistein were observed on the HER2negative breast cancer cell line MCF-7 or HER2-positive breast cancer cell lines BT-474 and MCF-7/Her2 derived from MCF-7, and ovarian cancer cell line SKOV-3. Results: The addition of genistein ranged from 1-10g/ml in the medium for 48 hours had a marked inhibition on the proliferation of HER2-positive cancer cell lines MCF-7/Her2, BT-474 and SKOV-3, compared with tamoxifen and DMSO control (P<0.01), and a dose-dependent response was presented. However, genistein exerted a weak inhibitive effect on HER2-negative breast cancer cell line MCF-7. There was a significant apoptosis or necrosis effect of BT-474 cells induced by 10 g/ml genistein for 12-48 hours in comparison with DMSO control (P<0.01), and a time-dependent response relationship. Moreover, genistein could down-regulate HER2 receptor expression and AKT kinase activity by using immunofluorescence and western blotting methods. Functional Foods in Health and Disease 2013; 3(7):291-299 Page 292 of 299 Conclusion: Our findings demonstrated that genistein could effectively inhibit the proliferation of HER2-positive cancer cell lines, which should be through down-regulating HER2 receptor and downstream signaling.

Bidirectional Regulation of Genistein on the Proliferation and Differentiation of C2C12 Myoblasts.

Genistein Promotes Skeletal Muscle Regeneration by Regulating Mir-221/222.

Mir-222 is Involved in the Regulation of Genistein on Skeletal Muscle Fiber Type

Effect and mechanism of genistein on the proliferation of MC3T3-E1 cells

Genistein Regulates Murine Osteoblasts and Osteoclasts via Receptor-Mediated Pathway

Genistein promotion of osteogenic differentiation through BMP2/SMAD5/RUNX2 signaling.

Comparative RNA-seq Analysis and Cerna Network of Genistein-Treated GT1-7 Neurons

Genistein stimulates the osteoblastic differentiation via NO/cGMP in bone marrow culture.

Inhibition of adipocyte differentiation by phytoestrogen genistein through a potential downregulation of extracellular signal-regulated kinases 1/2 activity.

Inhibitory actions of genistein in human breast cancer (MCF-7) cells

Genistein induces enhanced growth promotion in ER-positive/erbB-2-overexpressing breast cancers by ER-erbB-2 cross talk and p27/kip1 downregulation.

miR-222 Is Involved in the Amelioration Effect of Genistein on Dexamethasone-Induced Skeletal Muscle Atrophy

EFFECTS OF GENISTEIN ON TUMOR-ASSOCIATED GENE EXPRESSION IN MCF-7 CELLS

Genistein Modulates the Anti-Tumor Activity of Cisplatin in MCF-7 Breast and HT-29 Colon Cancer Cells

Effects of Genistein, Daidzein and Glycitein on the Osteogenic and Adipogenic Differentiation of Bone Marrow Stromal Cells and on the Adipogenic Trans-Differentiation of Osteoblasts

Genistein Inhibits the Proliferation of Human HER2-positive Cancer Cells by Downregulating HER2 Receptor

Effects of Genistein on biological behavior of human hepatocarcinoma cells in vitro

[Effects of Genistein on Cell Proliferation and Differentiation in Human Osteoblast].

Genistein Inhibits Lung Cancer Cell Stem-Like Characteristics by Modulating MnSOD and FoxM1 Expression

[Regulation of Genistein on the Levels of ERalpha, ERbeta Mrna in Uterine Endometrial Cancer Cells].

Effects of Genistein on Changes of Osteoblastic Biological Function Induced by Breast Cancer Cells